Sentinel lymph node biopsy (SLNB) is a minimally invasive procedure critical for staging various cancers, including breast cancer and melanoma. This technique identifies the first lymph node(s) to which cancer cells are most likely to spread, guiding treatment decisions. Indocyanine Green (ICG) has emerged as a superior tracer for sentinel lymph node biopsy support, offering significant advantages over traditional methods.


Traditionally, SLNB relies on radioactive tracers or blue dyes, which have limitations such as radiation exposure or allergic reactions. ICG, a near-infrared fluorescent dye, provides a safer and highly effective alternative. When injected near the tumor site, ICG is rapidly taken up by the lymphatic vessels and transported to the sentinel lymph nodes, which then fluoresce under near-infrared light. This real-time visualization allows surgeons to precisely locate and excise the sentinel nodes, ensuring accurate staging with minimal invasiveness.


The benefits of using Indocyanine Green for lymphatic mapping uses are numerous: it offers immediate visualization, allows for multiple injections, and has an excellent safety profile. The enhanced clarity provided by ICG fluorescence leads to higher detection rates of sentinel nodes, potentially reducing the need for more extensive lymph node dissections. Oncology centers looking to buy ICG supplier for oncology applications can rely on specialized manufacturers like NINGBO INNO PHARMCHEM CO.,LTD., who provide high-purity Indocyanine Green tailored for these critical procedures.


The integration of ICG into SLNB protocols represents a significant advancement in surgical oncology, improving precision, reducing complications, and ultimately enhancing patient care. Its ability to provide real-time, clear visualization of lymphatic pathways makes Indocyanine Green an indispensable tool in modern cancer management, continually pushing the boundaries of accurate diagnosis and targeted treatment.